BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 25884621)

  • 1. Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision.
    de Azevedo Santos TR; Tundisi CF; Ramos H; Maia MA; Pellizzon AC; Silva ML; Fogaroli RC; Chen MJ; Suzuki SH; Dias JE; Sanematsu PI; de Castro DG
    Radiat Oncol; 2015 Mar; 10():63. PubMed ID: 25884621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
    Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
    Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
    Yomo S; Hayashi M
    BMC Cancer; 2016 Dec; 16(1):948. PubMed ID: 27978813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection.
    Kurtz G; Zadeh G; Gingras-Hill G; Millar BA; Laperriere NJ; Bernstein M; Jiang H; Ménard C; Chung C
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):137-42. PubMed ID: 24331660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.
    Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):336-42. PubMed ID: 22652105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Large Brain Metastases With Stereotactic Radiosurgery.
    Zimmerman AL; Murphy ES; Suh JH; Vogelbaum MA; Barnett GH; Angelov L; Ahluwalia M; Reddy CA; Chao ST
    Technol Cancer Res Treat; 2016 Feb; 15(1):186-95. PubMed ID: 25633136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose.
    Moraes FY; Winter J; Atenafu EG; Dasgupta A; Raziee H; Coolens C; Millar BA; Laperriere N; Patel M; Bernstein M; Kongkham P; Zadeh G; Conrad T; Chung C; Berlin A; Shultz DB
    Neuro Oncol; 2019 Feb; 21(2):242-251. PubMed ID: 30265328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of whole-brain radiotherapy added to radiosurgery for brain metastases.
    Kong DS; Lee JI; Im YS; Nam DH; Park K; Kim JH
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):385-9. PubMed ID: 20097485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery.
    Raldow AC; Chiang VL; Knisely JP; Yu JB
    Am J Clin Oncol; 2013 Oct; 36(5):486-90. PubMed ID: 22706180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
    Clarke JW; Register S; McGregor JM; Grecula JC; Mayr NA; Wang JZ; Li K; Gupta N; Kendra KL; Olencki TE; Cavaliere R; Sarkar A; Lo SS
    Am J Clin Oncol; 2010 Feb; 33(1):70-4. PubMed ID: 19652578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereotatic radiosurgery of 468 brain metastases < or =2 cm: implications for SRS dose and whole brain radiation therapy.
    Shehata MK; Young B; Reid B; Patchell RA; St Clair W; Sims J; Sanders M; Meigooni A; Mohiuddin M; Regine WF
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):87-93. PubMed ID: 15093903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.
    Yomo S; Hayashi M
    J Neurooncol; 2013 Jul; 113(3):459-65. PubMed ID: 23661101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients.
    Pontoriero A; Conti A; Iatì G; Mondello S; Aiello D; Rifatto C; Risoleti E; Mazzei M; Tomasello F; Pergolizzi S; De Renzis C
    Neurosurg Rev; 2016 Jul; 39(3):495-504. PubMed ID: 27106896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma.
    Marcus DM; Lowe M; Khan MK; Lawson DH; Crocker IR; Shelton JW; Melton A; Maynard N; Delman KA; Carlson GW; Rizzo M
    Am J Clin Oncol; 2014 Dec; 37(6):580-4. PubMed ID: 23428955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.